Urinary Antigen Testing for Respiratory Infections: Current Perspectives on Utility and Limitations
Priscilla Kim,Abhishek Deshpande,Michael B Rothberg
DOI: https://doi.org/10.2147/IDR.S321168
2022-04-28
Infection and Drug Resistance
Abstract:Priscilla Kim, 1 Abhishek Deshpande, 2 Michael B Rothberg 2 1 Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, USA; 2 Center for Value-Based Care Research, Cleveland Clinic, Cleveland, Ohio, USA Correspondence: Michael B Rothberg, Center for Value-Based Care Research, Cleveland Clinic, 9500 Euclid Ave, Mail Code G10, Cleveland, OH, 44195, USA, Tel +1 216-445-5556, Email Pneumonia is a leading cause of hospitalization and death due to infection worldwide. Streptococcus pneumoniae and Legionella pneumophila remain among the most commonly identified bacterial pathogens. Unfortunately, more than half of all pneumonia cases today lack an etiologic diagnosis due to limitations in traditional microbiological methods like blood and sputum cultures, which are affected by poor sample collection, prior antibiotic administration, and delayed processing. Urinary antigen tests (UATs) for S. pneumoniae and L. pneumophila have emerged as powerful tools for improving the diagnosis of bacterial respiratory infections, enabling physicians to administer early directed therapy and improve antimicrobial stewardship. UATs are simple, rapid, and non-invasive diagnostic tests with high specificity (> 90%) and moderate sensitivity (80 years of age (164 cases per 10,000). 1,2 While Streptococcus pneumoniae remains the most commonly identified bacterial pathogen, other important causes include Mycoplasma pneumoniae, Staphylococcus aureus, Legionella pneumophila , Enterobacteriaceae, and Haemophilus influenzae . 1,3 Early identification of the causative pathogen in CAP is crucial to guide antibiotic therapy, prevent the emergence of antimicrobial resistance, and reduce drug toxicities. Unfortunately, approximately 50–60% of all CAP cases still lack an etiologic diagnosis due to limitations in traditional microbiological methods, such as blood/sputum cultures, which are affected by poor sample collection, delayed processing, and prior antibiotic administration. 1,2,4 Cultures usually take ≥48 hours before a specific bacterium can be identified. Moreover, among patients hospitalized with CAP, the rate of positive blood cultures is low, ranging from 4.7 to 16%, 5–13 while the diagnostic yield of sputum cultures is <50%. 14–16 One recent meta-analysis of 24 studies including 4533 adult CAP patients found that a bacterial pathogen was identified in only 36% of sputum specimens. 17 Urinary antigen tests (UATs) have emerged as a promising alternative for improving the diagnosis of respiratory infections caused by Streptococcus pneumoniae, Legionella pneumophila , and Histoplasma capsulatum . 2,18 UATs are non-culture-based tests that detect antigens shed from pathogens and excreted in the urine. UATs have several advantages over traditional microbiological methods; they are simple, non-invasive, rapid, and unaffected by prior antibiotic administration. 19 This review describes the current status of U -Abstract Truncated-
pharmacology & pharmacy,infectious diseases